Quarterly report · Q1

Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.2bn2023-10-01 → 2023-12-31Cons.Net sales
Revenue¥14.5bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥3.7bn2022-10-01 → 2022-12-31Cons.Net sales
Operating income¥496m2023-10-01 → 2023-12-31Cons.Operating income
Operating income¥467m2022-10-01 → 2022-12-31Cons.Operating income
Ordinary income¥486m2023-10-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.2bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥475m2022-10-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥486m2023-10-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥475m2022-10-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥290m2023-10-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥618m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥270m2022-10-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥294m2023-10-01 → 2023-12-31Cons.Profit loss
Net income¥268m2022-10-01 → 2022-12-31Cons.Profit loss
Total assets¥15.0bnat 2023-12-31Cons.Assets
Total assets¥15.2bnat 2023-09-30Cons.Assets
Total assets¥14.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥6.6bnat 2023-09-30Cons.Liabilities
Net assets / equity¥8.8bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.4bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.0bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-09-30Cons.Cash and deposits
EPS (basic)¥13.362023-10-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.332022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.422022-10-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.992022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥12.082022-10-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio56.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2023-12-31−¥204,000
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2023-12-31−¥204,000
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2023-12-31−¥341m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue2023-10-01 → 2023-12-31¥3.4bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2023-10-01 → 2023-12-31¥3.4bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥15,000
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2023-10-01 → 2023-12-31¥870m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2023-12-31¥115m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2023-12-31¥115m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2023-12-31−¥94m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2023-10-01 → 2023-12-31¥606m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2023-10-01 → 2023-12-31¥606m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥189,000
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2023-10-01 → 2023-12-31¥61m
—segment totalrevenue2023-10-01 → 2023-12-31¥4.2bn
—segment totalrevenue external2023-10-01 → 2023-12-31¥4.2bn
—segment totalrevenue intersegment2023-10-01 → 2023-12-31¥204,000
—segment totalsegment profit2023-10-01 → 2023-12-31¥837m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥346m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥3.0bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥3.0bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥2m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥803m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥123m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥122m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥1m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2022-12-31−¥18m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥570m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥570m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥150,000
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥28m
—segment totalrevenue2022-10-01 → 2022-12-31¥3.7bn
—segment totalrevenue external2022-10-01 → 2022-12-31¥3.7bn
—segment totalrevenue intersegment2022-10-01 → 2022-12-31¥3m
—segment totalsegment profit2022-10-01 → 2022-12-31¥813m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 356
ItemContextValueUnit
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass